Concepedia

Bettina Ammentorp

BA

4

Publications

508

Citations

4

H-Index

2012

Active since

Affiliations

Daiichi Sankyo (Germany)(Current)

St Thomas' Hospital

Université Paris Cité

University of Birmingham

University of Münster

Bettina Ammentorp is an author at Daiichi Sankyo (Germany) specializing in cardiovascular pharmacology, medicine, and pharmacology.

Top concepts

Publications per year

2012–2014

4

Publications

4

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)

Paulus Kirchhof, Bettina Ammentorp, Harald Darius et al. · EP Europace · 2013 · 408 citations · Full text

Efficacy and Safety of Triple Antihypertensive Therapy with the Olmesartan/Amlodipine/Hydrochlorothiazide Combination

Massimo Volpe, Lars Christian Rump, Bettina Ammentorp et al. · Clinical Drug Investigation · 2012 · 54 citations

, , +7

Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe

Raffaele De Caterina, Bettina Ammentorp, Harald Darius et al. · Heart · 2014 · 35 citations

Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension

Massimo Volpe, Alejandro de la Sierra, Bettina Ammentorp et al. · Advances in Therapy · 2014 · 11 citations

Rows per page

1–4 of 4